Rose Hill Acquisition Corporation

ROSENASDAQFinancial Services

$11.66

$-0.02(-0.17%)

Market Cap$61659701

P/E Ratio—

52W High$20.0

52W Low$10.33

Avg Volume52

Open$11.64

Beta0.00

Overview

Rose Hill Acquisition Corporation (ROSE) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

rose · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Rose Hill Acquisition Corporation (ROSE) measures how much investors pay for each dollar of the company's trailing earnings. ROSE's current PE ratio of 16.73x is calculated by dividing its stock price of $11.66 by its TTM earnings per share of $0.70. +60.2% elevated vs 5Y avg 10.4x

16.73x

P/E Ratio (TTM)+60.2%

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E

N/A

FY2021 est. EPS $-0.17

Based on 1 analyst

EPS (TTM)

$0.70

TTM · diluted EPS

PEG Ratio

-0.58

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Rose Hill Acquisition Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2022 · Annual

PE Ratio (TTM)

5Y Avg 10.4x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 4 fiscal years · Front-end computed

Average

10.4x

4-yr mean

Median

11.7x

4-yr midpoint

Minimum

1.4x

Lowest year

Maximum

17.0x

Highest year

16.7x ← Now

1.4x
MinQ1 · 25%11.7x
MedianQ3 · 75%17.0x
Max

Historically Elevated

At 16.73x, ROSE's current P/E is higher than in 75% of its annual fiscal year readings over the past 4 years — historically elevated.

75th percentileHigher than 3 of 4 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Rose Hill Acquisition CorporationYou ROSE	$62M	16.73x	-97.3%	$0.70
AEON Biopharma, Inc. AEON	$9M	N/A	—	-$3.95
A SPAC II Acquisition Corporation ASCB	$63M	N/A	—	-$0.91
Chenghe Acquisition Co. CHEA	$62M	41.10x	-93.4%	$0.25
Currenc Group, Inc. CURR	$232M	N/A	—	-$0.30
Golden Arrow Merger Corp. GAMC	$69M	N/A	—	-$4.14
Healthcare AI Acquisition Corp. HAIA	$63M	1199.22x	+93.4%	$0.01
Industry Average 2 peers with valid PE	—	620.16x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2022-12-31Latest FY2022	14.81x	$0.70	-100.0%
2021-12-31 FY2021	—	$0.00	+364924.4%
2019-12-31 FY2019	17.01x	$0.58	+1118.0%
2018-12-31 FY2018	1.40x	$7.08	-83.7%
2017-12-31 FY2017	8.56x	$1.15	—
2016-12-31 FY2016	—	$-0.55	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $11.66 ÷ $0.70 = 16.73x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

ROSE pe ratio · 6 questions

ROSE's current PE ratio is 16.73x as of 2026-06-09, based on a stock price of $11.66 and TTM EPS of $0.70. Data sourced from Financial Modeling Prep via ROSE's SEC 10-K and 10-Q filings.

ROSE PE ratioWhat is ROSE PE ratioCurrent PE ratio of ROSEROSE PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Rose Hill Acquisition Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09